Anti-Saccharomyces cerevisiae antibodies (ASCA), phenotypes of IBD, and intestinal permeability: A study in IBD families

Inflammatory Bowel Diseases

Volumn 7, Issue 1, 2001, Pages 8-15

  Friedman, Sonia ^a,b   Marion, James F ^a   Scherl, Ellen ^a   Rubin, Peter H ^a   Present, Daniel H ^a  

^a MOUNT SINAI MEDICAL CENTER   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Inflammatory bowel disease; Serological markers

Indexed keywords

EDETATE CHROMIUM CR 51; FUNGUS ANTIBODY; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; BELGIUM; CELL NUCLEUS; COHORT ANALYSIS; COLON CROHN DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE PREDISPOSITION; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FAMILIAL DISEASE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOTHESIS; IMMUNOFLUORESCENCE TEST; IMMUNOLOGY; IMMUNOPATHOGENESIS; INTESTINE MUCOSA PERMEABILITY; KINETICS; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; RELATIVE; SACCHAROMYCES CEREVISIAE; SEROLOGY; SMALL INTESTINE; SPOUSE; STAINING;

EID: 0035015975     PISSN: 10780998     EISSN: None     Source Type: Journal    
DOI: 10.1097/00054725-200102000-00002     Document Type: Article

References (38)

1. A new type of perinuclear anti-neutrophil cytoplasmic antibody (p-ANCA) in active ulcerative colitis but not in Crohn's disease
2. A distinct subset of anti-neutrophil cytoplasmic antibodies is associated with inflammatory bowel disease
3. Anti-neutrophil cytoplasmic antibodies in ulcerative colitis: Comparison with other colitides/diarrhoeal illnesses
4. Anti-neutrophil antibodies in inflammatory bowel disease: Prevalence and diagnostic role
5. HLA, Antineutrophil cytoplasmic autoantibody and heterogeneity in ulcerative colitis
6. The presence of anti-neutrophil antibodies reflects clinical and genetic heterogeneity within inflammatory bowel disease
7. Perinuclear anti-neutrophil cytoplasmic antibodies are spontaneously produced by mucosal B cells of ulcerative colitis patients
8. Seggregation of pANCA antigenic recognition by DNAse treatment of neutrophils: Ulcerative colitis, type I autoimmune hepatitis and primary sclerosing cholangitis
9. A typical Antineutrophil cytoplasmic antibodies with perinuclear fluorescence in chronic inflammatory bowel disease and hepatobiliary disorders colocalize with nuclear lamina proteins
10. Low prevalence of anti-neutrophil cytoplasmic antibodies in ulcerative colitis patients with long-term remission
11. Antineutrophil cytoplasmic antibody correlates with chronic pouchitis after ileal pouch-anal anastomosis
12. Perinuclear Antineutrophil Cytoplasmic Antibodies in Patients with Crohn's disease define a clinical subgroup
13. Neutrophil autoantibodies in ulcerative colitis: Familial aggregation and genetic heterogeneity
14. Neutrophil autoantibodies: A genetic marker in primary sclerosing cholangitis and ulcerative colitis
15. Antinuclear Autoantibodies in patients with inflammatory bowel disease-high prevalence in first-degree relatives
16. Antineutrophil cytoplasmic autoantibodies in relatives of patients with ulcerative colitis
17. Antineutrophil antibodies in familial inflammatory bowel disease
18. pANCA in monozygotic twins with inflammatory bowel disease
19. Antibody to Saccharomyces cerevisiae (baker's yeast) in Crohn's disease
20. Specific antibody response to oligomannosidic epitopes in Crohn's disease
21. Anti-Saccharomyces cereviasiae mannan antibodies combined with anti-neutrophil cytoplasmic autoantibodies in inflammatory bowel disease: Prevalence and diagnostic role
22. Diagnostic accuracy of serological assays in pediatric inflammatory bowel disease
23. Clinical value of the detection of antibodies in the serum for diagnosis and treatment of inflammatory bowel disease
24. Anti-Saccharomyces cerevisiae mannan antibodies in familial Crohn's disease
25. Familial expression of anti-Saccharomyces cerevisiae mannan antibodies in affected and un-affected relatives of patients with Crohn's disease
26. Intestinal permeability and the prediction of relapse in Crohn's disease
27. Intestinal permeability in patients with Crohn's disease and their first degree relatives
28. Is small intestinal permeability really increased in relatives of patients with Crohn's disease?
29. Permeability in Crohn's disease: Altered barrier function in healthy relatives?
30. Intestinal permeability in patients with Crohn's disease and ulcerative colitis and their first degree relatives
31. Clustering of increased small intestinal permeability in families with Crohn's disease
32. Different intestinal permeability patterns in relatives and spouses of patients with Crohn's disease: An inherited defect in mucosal defence?
33. Classification of inflammatory bowel disease
34. Intestinal permeability: An overview
35. Test conditions greatly influence permeation of water soluble molecules through the intestinal mucosa: Need for standardisation
36. The prevalence of inflammatory bowel disease in relatives of patients with Crohn's disease
37. Familial aggregation of inflammatory bowel disease in northern Italy: A multicenter study
38. Incidence of inflammatory bowel disease in Northern France (1988-1990)